- Home
- AVNT vs IMVT Comparison
AVNT vs IMVT Comparison
Compare AVNT & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNT
- IMVT
- Stock Information
- Founded
- AVNT 1927
- IMVT N/A
- Country
- AVNT United States
- IMVT United States
- Employees
- AVNT N/A
- IMVT N/A
- Industry
- AVNT Major Chemicals
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVNT Industrials
- IMVT Health Care
- Exchange
- AVNT Nasdaq
- IMVT Nasdaq
- Market Cap
- AVNT 3.4B
- IMVT 3.4B
- IPO Year
- AVNT 1993
- IMVT N/A
- Fundamental
- Price
- AVNT $30.64
- IMVT $14.40
- Analyst Decision
- AVNT Strong Buy
- IMVT Strong Buy
- Analyst Count
- AVNT 5
- IMVT 10
- Target Price
- AVNT $54.40
- IMVT $43.57
- AVG Volume (30 Days)
- AVNT 667.9K
- IMVT 2.2M
- Earning Date
- AVNT 05-06-2025
- IMVT 05-28-2025
- Dividend Yield
- AVNT 3.30%
- IMVT N/A
- EPS Growth
- AVNT 121.98
- IMVT N/A
- EPS
- AVNT 1.84
- IMVT N/A
- Revenue
- AVNT $3,240,400,000.00
- IMVT N/A
- Revenue This Year
- AVNT $3.54
- IMVT $108.88
- Revenue Next Year
- AVNT $4.50
- IMVT N/A
- P/E Ratio
- AVNT $20.58
- IMVT N/A
- Revenue Growth
- AVNT 3.11
- IMVT N/A
- 52 Week Low
- AVNT $32.48
- IMVT $14.90
- 52 Week High
- AVNT $54.68
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- AVNT 24.46
- IMVT 32.30
- Support Level
- AVNT $36.01
- IMVT $14.90
- Resistance Level
- AVNT $37.97
- IMVT $18.96
- Average True Range (ATR)
- AVNT 1.28
- IMVT 1.36
- MACD
- AVNT -0.47
- IMVT -0.33
- Stochastic Oscillator
- AVNT 0.29
- IMVT 1.66
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).